‘Fen-Phen’ Valve Damage Seen With Parkinson's Agents: Too soon for a moratorium on drugs' use.

Patients with Parkinson's disease who received the drugs pergolide or cabergoline had profoundly higher rates of clinically significant valvular heart disease than did those taking other dopamine agonists, in two European studies.